Clinical Trials Logo

Muscle Cramp clinical trials

View clinical trials related to Muscle Cramp.

Filter by:

NCT ID: NCT03085745 Recruiting - Writer's Cramp Clinical Trials

Sensorimotor Mapping in Patients With Writer's Cramp

IWCToxin
Start date: February 20, 2017
Phase: N/A
Study type: Interventional

Writer's cramp (WC) is a form of focal dystonia, a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive movements, postures, or both. It typically manifests while writing, making handwriting impossible in the most severe cases. Treatment can be difficult, but one effective and well-tolerated treatment consists in local muscle injections with botulinum toxin. Although clinical improvement seems to be related to focal muscle chemodenervation, central plasticity changes may occur. The main aim of the study is to characterize and quantify the changes in intrinsic hand muscle cortical representations at rest and during isometric contractions of the finger muscles before and after treatment with botulinum toxin and the changes in sensorimotor integration in patients with writer's cramp.

NCT ID: NCT02642874 Recruiting - Liver Cirrhosis Clinical Trials

Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients

Start date: April 1, 2017
Phase: Phase 3
Study type: Interventional

Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.

NCT ID: NCT02423395 Recruiting - Liver Cirrhosis Clinical Trials

Study of Orphenadrine` in the Treatment of Muscle Cramps in Patients With Cirrhosis

Start date: January 2015
Phase: Phase 3
Study type: Interventional

Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. [3,4]

NCT ID: NCT02221570 Recruiting - Liver Cirrhosis Clinical Trials

Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis

Start date: June 2014
Phase: N/A
Study type: Interventional

Patients with cirrhosis often experience muscle cramps with varying severity. The mechanism of their occurrence is not yet understood. Muscle cramps in patients with cirrhosis are associated with significantly diminished quality of life. The aim of the study is to assess the efficacy of baclofen in the treatment of muscle cramps in patients with liver cirrhosis.